Mannitol: It has not been demonstrated to be effective in managing cerebral edema caused by hyperammonemia and therefore, it should not be given, 43 strong recommendation, low quality evidence (1C)
10.1002/aur.239 5
Most published studies are small, involve patients affected by obesity and/or T2DM, and may therefore not be fully generalizable to the broader PsO/PsA population
Growths that appear in covered areas (e.g., scalp, medial buttocks, perianal, genital areas) that are difficult to examine and follow are considered for early excision
L-Carnitine is offered strictly as a research-use-only laboratory material
This article reviews current evidence on GLP-1 therapies and CKD progression, including biomarker data, clinical trial findings, and the potential role of these agents within evolving kidney disease treatment strategies